Annotation Detail for PCDHA2
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| P00012 | Cadherin signaling pathway |
| P00057 | Wnt signaling pathway |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D001374 |
Azacitidine |
Azacitidine affects the methylation of PCDHA2 promoter | affects methylation | 18204046
|
| D013755 |
Tetradecanoylphorbol Acetate |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCDHA2 mRNA | affects cotreatment|affects expression | 16979875
|
| D015032 |
Zinc |
[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCDHA2 mRNA | affects cotreatment|affects expression | 16979875
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000169 |
Acrodermatitis |
|
Zinc |
6.15 | 17190629 16889938 17202136 |
| MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.82 | 16580781 17119284 16410023 16325427 |
| MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
5.49 | 16916123 |
| MESH:D001249 |
Asthma |
|
Zinc |
3.05 | 17085522 |
| MESH:D001930 |
Brain Injuries |
|
Zinc |
5.34 | 17109824 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
5.46 | 18922899 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
5.46 | 16543248 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.95 | 16936243 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.73 | 19934284 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
2.44 | 19302082 |
| MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.62 | 16479319 |
| MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
4.09 | 7812673 8273558 9599246 15177302 16716910 11698051 8113982 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
2.94 | 16543248 |
| MESH:D005756 |
Gastritis |
|
Zinc |
5.66 | 17241300 |
| MESH:D006130 |
Growth Disorders |
|
Zinc |
4.22 | 17217573 |
| MESH:D006333 |
Heart Failure |
|
Zinc |
3.85 | 17162251 |
| MESH:D006335 |
Heart Injuries |
|
Zinc |
6.64 | 17074742 |
| MESH:D016481 |
Helicobacter Infections |
|
Zinc |
5.06 | 17241300 |
| MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
5.34 | 17276780 |
| MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
3.28 | 8273558 7812673 11698051 7562506 15177302 |
| MESH:D007511 |
Ischemia |
|
Zinc |
5.28 | 16584753 |
| MESH:D007674 |
Kidney Diseases |
|
Zinc |
3.54 | 16960431 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.90 | 16518626 |
| MESH:D007938 |
Leukemia |
|
Azacitidine |
3.87 | 19148494 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
5.11 | 19077051 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
3.05 | 17596541 18720364 |
| MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.72 | 19299654 |
| MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
3.16 | 21224363 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.16 | 11807781 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
7.40 | 8985016 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
7.40 | 12773700 |
| MESH:D009006 |
Monosomy |
|
Azacitidine |
6.95 | 19299654 |
| MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
4.27 | 18443271 19549372 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
4.22 | 19805378 17611569 17596541 18720364 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.25 | 15976015 |
| MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.94 | 12065085 18404319 8330346 18922899 |
| MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.52 | 17114810 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
3.72 | 18324645 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.72 | 16517595 12429649 16606632 16700911 |
| MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.45 | 16584753 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
3.45 | 8985016 18404319 11807781 8330346 12065085 |
| MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.85 | 16543248 |
Related Diseases/Disorders